Geri

A COMPARISON OF TWO DIFFERENT SEDATION TECHNIQUES IN GERIATRIC PATIENTS FOR ENDOSCOPIC UROLOGICAL SURGERY

Article

Volume 15, Issue 1

January 2012 · Pages 055-060

A COMPARISON OF TWO DIFFERENT SEDATION TECHNIQUES IN GERIATRIC PATIENTS FOR ENDOSCOPIC UROLOGICAL SURGERY

Jale Bengi ÇELİK1, Ahmet TOPAL2, Tuba Berra ERDEM2, İnci KARA1

1Selçuk Ünviversitesi Selçuklu Tıp Fakültesi Anesteziyoloji ve Reanimasyon Anabilim Dalı KONYA
2Selçuk Üniversitesi Meram Tıp Fakültesi Anesteziyoloji ve Reanimasyon Anabilim Dalı KONYA
Keywords: Propofol Ketamine Conscious Sedation Geriatrics

Introduction: In this study, we evaluated the effectiveness and safety of intravenous propofol- fentanyl and ketamine-midazolam combinations for procedural sedation and analgesia in elderly patients undergoing urological endoscopic surgery.

Materials and Method: This prospective study enrolled 80 patients aged 60-80 years ASA I-III requiring endoscopic urological procedures. Patients received intravenous bolus doses of either fentanyl 1 μg.kg-1 and propofol 1-2 mg.kg-1 in group P or ketamine 1-1.5 mg.kg-1 and midazolam 0.1 mg.kg-1 in group K titrated according to Ramsay sedation scale in the range of 3-4.

Results: There were no differences in vital signs, operating times and demographic variables. Time to Aldrete score ≥8 was similar in two groups. Time to PADSS ≥9 was significantly longer in group K than group P (p<0.05). The frequency of vertigo, nausea, vomiting, visual disturbances, laryngeal spasm and hallucinations were higher in group K (p<0.05). But pain of injection and respiratory depression were more frequent in group P (p<0.05). Excessive salivation, tachycardia, bradycardia, hypotension, hypertension were similar in both groups.

Conclusion: Hemodynamic changes and degrees of sedation showed that propofol-fentanyl and ketamine-midazolam combinations can safely be used in geriatric patients undergoing endoscopic urological procedures. However, in the propofol-fentanyl group the incidence of side effects were lower and the recovery period was shorter than the ketamine-midazolam group.